Meta-analysis of second-trimester markers for trisomy 21

Ultrasound in Obstetrics and Gynecology

Volumn 41, Issue 3, 2013, Pages 247-261

  Agathokleous, M ^a   Chaveeva, P ^a   Poon, L C Y ^a   Kosinski, P ^a   Nicolaides, K H ^a,b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Down syndrome; pyramid of care; second trimester screening; sonographic markers; trisomy 21

Indexed keywords

DOWN SYNDROME; ECHOGRAPHY; FEMALE; FETUS ECHOGRAPHY; HUMAN; META ANALYSIS; METHODOLOGY; PREGNANCY; PRENATAL DIAGNOSIS; REVIEW; RISK FACTOR; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY;

DOWN SYNDROME; FEMALE; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, PRENATAL;

EID: 84874732295     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.12364     Document Type: Review

References (61)

1. Bahado-Singh RO, Goldstein I, Uerpairojkit B, Copel JA, Mahoney MJ, Baumgarten A,. Normal nuchal thickness in the midtrimester indicates reduced risk of Down syndrome in pregnancies with abnormal triple-screen results. Am J Obstet Gynecol 1995; 173: 1106-1110.
2. DeVore GR, Alfi O,. The use of color Doppler ultrasound to identify fetuses at increased risk for trisomy 21: an alternative for high-risk patients who decline genetic amniocentesis. Obstet Gynecol 1995; 85: 378-386.
3. Grandjean H, Sarramon MF,. Sonographic measurement of nuchal skinfold thickness for detection of Down syndrome in the second-trimester fetus: a multicenter prospective study. The AFDPHE Study Group. Association Française pour le Dépistage et la Prévention des Handicaps de l'Enfant. Obstet Gynecol 1995; 85: 103-106.
4. Grandjean H, Sarramon MF,. Femur/foot length ratio for detection of Down syndrome: results of a multicenter prospective study. The Association Française pour le Dépistage et la Prévention des Handicaps de l'Enfant Study Group. Am J Obstet Gynecol 1995; 173: 16-19.
5. Nyberg DA, Luthy DA, Cheng EY, Sheley RC, Resta RG, Williams MA,. Role of prenatal ultrasonography in women with positive screen for Down syndrome on the basis of maternal serum markers. Am J Obstet Gynecol 1995; 173: 1030-1035.
6. Vintzileos AM, Campbell WA, Rodis JF, Guzman ER, Smulian JC, Knuppel RA,. The use of second-trimester genetic sonogram in guiding clinical management of patients at increased risk for fetal trisomy 21. Obstet Gynecol 1996; 87: 948-952.
7. Vintzileos AM, Egan JF, Smulian JC, Campbell WA, Guzman ER, Rodis JF,. Adjusting the risk for trisomy 21 by a simple ultrasound method using fetal long-bone biometry. Obstet Gynecol 1996; 87: 953-958.
8. Deren O, Mahoney MJ, Copel JA, Bahado-Singh RO,. Subtle ultrasonographic anomalies: do they improve the Down syndrome detection rate? Am J Obstet Gynecol 1998; 178: 441-445.
9. Manning JE, Ragavendra N, Sayre J, Laifer-Narin SL, Melany ML, Grant EG, Crandall BF,. Significance of fetal intracardiac echogenic foci in relation to trisomy 21: a prospective sonographic study of high-risk pregnant women. AJR Am J Roentgenol 1998; 170: 1083-1084.
10. Sohl BD, Scioscia AL, Budorick NE, Moore TR,. Utility of minor ultrasonographic markers in the prediction of abnormal fetal karyotype at a prenatal diagnostic center. Am J Obstet Gynecol 1999; 181: 898-903.
11. Tannirandorn Y, Manotaya S, Uerpairojkit B, Tanawattanacharoen S, Charoenvidhya D, Phaosavasdi S,. Cut-off criteria for second-trimester nuchal skinfold thickness for prenatal detection of Down syndrome in a Thai population. Int J Gynaecol Obstet 1999; 65: 137-141.
12. Vergani P, Locatelli A, Piccoli MG, Ceruti P, Mariani E, Pezzullo JC, Ghidini A,. Best second trimester sonographic markers for the detection of trisomy 21. J Ultrasound Med 1999; 18: 469-473.
13. Wax JR, Guilbert J, Mather J, Chen C, Royer D, Steinfeld JD, Ingardia CJ,. Efficacy of community-based second trimester genetic ultrasonography in detecting the chromosomally abnormal fetus. J Ultrasound Med 2000; 19: 689-694.
14. Winter TC, Anderson AM, Cheng EY, Komarniski CA, Souter VL, Uhrich SB, Nyberg DA,. Echogenic intracardiac focus in 2nd-trimester fetuses with trisomy 21: usefulness as a US marker. Radiology 2000; 216: 450-456.
15. Nyberg DA, Souter VL, El-Bastawissi A, Young S, Luthhardt F, Luthy DA,. Isolated sonographic markers for detection of fetal Down syndrome in the second trimester of pregnancy. J Ultrasound Med 2001; 20: 1053-1063.
16. Prefumo F, Presti F, Mavrides E, Sanusi AF, Bland JM, Campbell S, Carvalho JS,. Isolated echogenic foci in the fetal heart: do they increase the risk of trisomy 21 in a population previously screened by nuchal translucency? Ultrasound Obstet Gynecol 2001; 18: 126-130.
17. Viora E, Errante G, Bastonero S, Sciarrone A, Campogrande M,. Minor sonographic signs of trisomy 21 at 15-20 weeks' gestation in fetuses born without malformations: a prospective study. Prenat Diagn 2001; 21: 1163-1166.
18. Bahado-Singh RO, Mendilcioglu I, Rowther M, Choi SJ, Oz U, Yousefi NF, Mahoney MJ,. Early genetic sonogram for Down syndrome detection. Am J Obstet Gynecol 2002; 187: 1235-1238.
19. Bromley B, Lieberman E, Shipp TD, Benacerraf BR,. Fetal nose bone length: a marker for Down syndrome in the second trimester. J Ultrasound Med 2002; 21: 1387-1394.
20. Bromley B, Lieberman E, Shipp TD, Benacerraf BR,. The genetic sonogram: a method of risk assessment for Down syndrome in the second trimester. J Ultrasound Med 2002; 21: 1087-1096.
21. Vintzileos AM, Guzman ER, Smulian JC, Yeo L, Scorza WE, Knuppel RA,. Down syndrome risk estimation after normal genetic sonography. Am J Obstet Gynecol 2002; 187: 1226-1229.
22. Bunduki V, Ruano R, Miguelez J, Yoshizaki CT, Kahhale S, Zugaib M,. Fetal nasal bone length: reference range and clinical application in ultrasound screening for trisomy 21. Ultrasound Obstet Gynecol 2003; 21: 156-160.
23. Cicero S, Sonek JD, McKenna DS, Croom CS, Johnson L, Nicolaides KH,. Nasal bone hypoplasia in trisomy 21 at 15-22 weeks' gestation. Ultrasound Obstet Gynecol 2003; 21: 15-18.
24. Vintzileos A, Walters C, Yeo L,. Absent nasal bone in the prenatal detection of fetuses with trisomy 21 in a high-risk population. Obstet Gynecol 2003; 101: 905-908.
25. Coco C, Jeanty P, Jeanty C,. An isolated echogenic heart focus is not an indication for amniocentesis in 12,672 unselected patients. J Ultrasound Med 2004; 23: 489-496.
26. Cusick W, Provenzano J, Sullivan CA, Gallousis FM, Rodis JF,. Fetal nasal bone length in euploid and aneuploid fetuses between 11 and 20 weeks' gestation: a prospective study. J Ultrasound Med 2004; 23: 1327-1333.
27. Gámez F, Ferreiro P, Salmeán JM,. Ultrasonographic measurement of fetal nasal bone in a low-risk population at 19-22 gestational weeks. Ultrasound Obstet Gynecol 2004; 23: 152-153.
28. Odibo AO, Sehdev HM, Dunn L, McDonald R, Macones GA,. The association between fetal nasal bone hypoplasia and aneuploidy. Obstet Gynecol 2004; 104: 1229-1233.
29. Coco C, Jeanty P,. Isolated fetal pyelectasis and chromosomal abnormalities. Am J Obstet Gynecol 2005; 193: 732-738.
30. Schluter PJ, Pritchard G,. Mid trimester sonographic findings for the prediction of Down syndrome in a sonographically screened population. Am J Obstet Gynecol 2005; 192: 10-16.
31. Tran LT, Carr DB, Mitsumori LM, Uhrich SB, Shields LE,. Second-trimester biparietal diameter/nasal bone length ratio is an independent predictor of trisomy 21. J Ultrasound Med 2005; 24: 805-810.
32. Viora E, Errante G, Sciarrone A, Bastonero S, Masturzo B, Martiny G, Campogrande M,. Fetal nasal bone and trisomy 21 in the second trimester. Prenat Diagn 2005; 25: 511-515.
33. Odibo AO, Sehdev HM, Sproat L, Parra C, Odibo L, Dunn L, Macones GA,. Evaluating the efficiency of using second-trimester nasal bone hypoplasia as a single or a combined marker for fetal aneuploidy. J Ultrasound Med 2006; 25: 437-441.
34. Cusick W, Shevell T, Duchan LS, Lupinacci CA, Terranova J, Crombleholme WR,. Likelihood ratios for fetal trisomy 21 based on nasal bone length in the second trimester: how best to define hypoplasia? Ultrasound Obstet Gynecol 2007; 30: 271-274.
35. Gianferrari EA, Benn PA, Dries L, Brault K, Egan JF, Zelop CM,. Absent or shortened nasal bone length and the detection of Down Syndrome in second-trimester fetuses. Obstet Gynecol 2007; 109: 371-375.
36. Sacco A, Coco C, Mangiafico L, Cignini P, Tiezzi A, Giorlandino C,. Prenatal Aneuploidies Computerized Screening (SCA TEST): a pilot study on 1000 women. J Prenat Med 2007; 1: 47-56.
37. Smith-Bindman R, Chu P, Goldberg JD,. Second trimester prenatal ultrasound for the detection of pregnancies at increased risk of Down syndrome. Prenat Diagn 2007; 27: 535-544.
38. Weisz B, Pandya PP, David AL, Huttly W, Jones P, Rodeck CH,. Ultrasound findings after screening for Down syndrome using the integrated test. Obstet Gynecol 2007; 109: 1046-1052.
39. Zalel Y, Achiron R, Yagel S, Kivilevitch Z,. Fetal aberrant right subclavian artery in normal and Down syndrome fetuses. Ultrasound Obstet Gynecol 2008; 31: 25-29.
40. Persico N, Borenstein M, Molina F, Azumendi G, Nicolaides KH,. Prenasal thickness in trisomy-21 fetuses at 16-24 weeks of gestation. Ultrasound Obstet Gynecol 2008; 32: 751-754.
41. Vergani P, Ghidini A, Weiner S, Locatelli A, Pozzi E, Biffi A,. Risk assessment for Down syndrome with genetic sonogram in women at risk. Prenat Diagn 2008; 28: 1144-1148.
42. Aagaard-Tillery KM, Malone FD, Nyberg DA, Porter TF, Cuckle HS, Fuchs K, Sullivan L, Comstock CH, Saade GR, Eddleman K, Gross S, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Bianchi DW, D'Alton ME; First and Second Trimester Evaluation of Risk Research Consortium. Role of second-trimester genetic sonography after Down syndrome screening. Obstet Gynecol 2009; 114: 1189-1196.
43. Bottalico JN, Chen X, Tartaglia M, Rosario B, Yarabothu D, Nelson L,. Second-trimester genetic sonogram for detection of fetal chromosomal abnormalities in a community-based antenatal testing unit. Ultrasound Obstet Gynecol 2009; 33: 161-168.
44. Shanks AL, Odibo AO, Gray DL,. Echogenic intracardiac foci: associated with increased risk for fetal trisomy 21 or not? J Ultrasound Med 2009; 28: 1639-1643.
45. Borenstein M, Minekawa R, Zidere V, Nicolaides KH, Allan LD,. Aberrant right subclavian artery at 16 to 23 + 6 weeks of gestation: a marker for chromosomal abnormality. Ultrasound Obstet Gynecol 2010; 36: 548-552.
46. Huang SY, Shaw SW, Cheuh HY, Cheng PJ,. Intracardiac echogenic focus and trisomy 21 in a population previously evaluated by first-trimester combined screening. Acta Obstet Gynecol Scand 2010; 89: 1017-1023.
47. Sooklim R, Manotaya S,. Fetal facial sonographic markers for second trimester Down syndrome screening in a Thai population. Int J Gynaecol Obstet 2010; 111: 144-147.
48. Carbone JF, Tuuli MG, Dicke JM, Macones GA, Odibo AO,. Revisiting the risk for aneuploidy in fetuses with isolated pyelectasis. Prenat Diagn 2011; 31: 566-570.
49. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
50. nd edn). Oxford University Press: New York, 1999.
51. Higgins JP, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
52. Sotiriadis A, Makrydimas G, Ioannidis JP,. Diagnostic performance of intracardiac echogenic foci for Down syndrome: a meta-analysis. Obstet Gynecol 2003; 101: 1009-1016.
53. Smith-Bindman R, Hosmer W, Feldstein VA, Deeks JJ, Goldberg JD,. Second-trimester ultrasound to detect fetuses with Down syndrome: a meta-analysis. JAMA 2001; 285: 1044-1055.
54. Salomon LJ, Bernard JP, Taupin P, Benard C, Ville Y,. Relationship between nuchal translucency at 11-14 weeks and nuchal fold at 20-24 weeks of gestation. Ultrasound Obstet Gynecol 2001; 18: 636-637.
55. Pandya PP, Snijders RJM, Johnson S, Nicolaides KH,. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness. Ultrasound Obstet Gynecol 1995; 5: 381-383.
56. Maymon R, Zimerman AL, Weinraub Z, Herman A, Cuckle H,. Correlation between nuchal translucency and nuchal skin-fold measurements in Down syndrome and unaffected fetuses. Ultrasound Obstet Gynecol 2008; 32: 501-505.
57. Miguelez J, De Lourdes Brizot M, Liao AW, De Carvalho MH, Zugaib M,. Second-trimester soft markers: relation to first-trimester nuchal translucency in unaffected pregnancies. Ultrasound Obstet Gynecol 2012; 39: 274-278.
58. Vintzileos AM, Egan JF,. Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography. Am J Obstet Gynecol 1995; 172: 837-844.
59. Nadel AS, Bromley B, Frigoletto FD Jr, Benacerraf BR,. Can the presumed risk of autosomal trisomy be decreased in fetuses or older women following a normal sonogram? J Ultrasound Med 1995; 14: 297-302.
60. Bahado-Singh RO, Tan A, Deren O, Hunter D, Copel J, Mahoney MJ,. Risk of Down syndrome and any clinically significant chromosome defect in pregnancies with abnormal triple-screen and normal targeted ultrasonographic results. Am J Obstet Gynecol 1996; 175: 824-829.
61. Nicolaides KH,. Screening for chromosomal defects. Ultrasound Obstet Gynecol 2003; 21: 313-321.